Independent Coverage of Israel's Technology Sector

We analyze publicly-listed Israeli tech companies using SEC filings, earnings call transcripts, and public financial data — not PR handouts. Focus on mid-cap firms between $500M and $5B that most outlets overlook.

120+ Public Israeli tech firms tracked
3 Core sectors: Cyber, Agritech, Medtech
Weekly Updated with new earnings analysis
SEC Primary source for all company data

What We Cover

Three areas where Israeli technology has disproportionate global influence. We follow the publicly traded companies — the ones with real numbers you can verify.

Cybersecurity

Israel punches far above its weight in cybersecurity. We track Check Point, CyberArk, Wiz and others — analyzing their quarterly filings, product evolution, and competitive positioning. This sector alone accounts for a significant chunk of the NASDAQ-listed Israeli tech stocks. Our approach: compare what companies tell investors on earnings calls against what their 10-K filings actually show.

Agricultural Technology

From drip irrigation to precision farming platforms, Israeli agritech has reshaped how food gets grown globally. We examine the public companies — Netafim's trajectory before the Mexichem acquisition, Taranis, CropX, and the broader ecosystem. These aren't just nice stories about saving water; they're businesses with revenue models, churn rates, and gross margins you can trace through public disclosures.

Medical Devices

Israel has produced some of the most widely-used medical imaging and surgical robotics companies. Given Imaging (the PillCam) put Israeli medtech on the map. We cover the next generation — focusing on FDA filings, clinical trial results, and Medicare reimbursement timelines. The intersection of hardware engineering and regulatory science makes this the most complex, and rewarding, sector to analyze.

Latest Analysis

In-depth articles based on public filings, earnings transcripts, and industry data.

Frequently Asked Questions

Honest answers about what this site is, and what it isn't.

Is OceanView an investment advisory service?

No. We do not make stock recommendations, buy/sell calls, or price targets. Our analysis is descriptive — we explain what companies do, what their filings say, and how their industry works. Any financial decision you make is yours alone. If you're looking for personalized investment advice, you need a licensed financial advisor.

Where does your data come from?

Almost entirely from sources anyone can access: SEC EDGAR filings (10-K, 10-Q, 8-K, S-1), earnings call transcripts via the SEC website or company investor relations pages, FDA databases for medical devices, and industry reports from research firms like Gartner and IDC. We cite specific documents so readers can verify every claim. Occasionally we reference Israeli regulatory filings from the Tel Aviv Stock Exchange (TASE) for dual-listed companies.

Who writes these articles and what's their background?

John Johnson is the primary analyst. He has spent over 12 years tracking Israeli technology companies, with a background in financial research and corporate strategy analysis in Tel Aviv. Every article carries a byline, publication date, and last-updated date so you know what you're reading and when it was current.

Do you get paid by the companies you cover?

No. OceanView does not accept payment from companies we analyze, and we don't hold positions in the stocks we discuss. This is an independent research publication. Our content is freely available. If we ever introduce any commercial relationship with a covered company, it will be clearly disclosed at the top of the relevant article.

Can I trust the accuracy of this information?

We aim for accuracy by sourcing everything to public documents you can check yourself. That said, public filings can contain errors, and our interpretation might be wrong. If you spot a mistake, email us and we'll correct it with a dated note. Technology and financial data moves fast — always check the date on any article you're reading.

Content Boundaries

OceanView is an independent technology research publication. We describe and analyze publicly-listed Israeli technology companies. We do not provide investment, legal, or tax advice. We do not sell financial products. We do not promise investment returns. All information should be independently verified. Read our full Disclaimer for details.

Get in Touch